Literature DB >> 28391265

ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Biochemical Markers.

Kjell Oberg1, Anne Couvelard, Gianfranco Delle Fave, David Gross, Ashley Grossman, Robert T Jensen, Ulrich-Frank Pape, Aurel Perren, Guido Rindi, Philippe Ruszniewski, Jean-Yves Scoazec, Staffan Welin, Bertram Wiedenmann, Diego Ferone.   

Abstract

Entities:  

Year:  2017        PMID: 28391265     DOI: 10.1159/000472254

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


× No keyword cloud information.
  38 in total

Review 1.  Echocardiography in functional midgut neuroendocrine tumors: When and how often.

Authors:  Javier G Castillo; Tara Naib; Jerome S Zacks; David H Adams
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 2.  Management of functional neuroendocrine tumors of the pancreas.

Authors:  Kjell Öberg
Journal:  Gland Surg       Date:  2018-02

3.  Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines.

Authors:  Stephan Petersenn; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 4.  Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important.

Authors:  Xi-Feng Jin; Matilde P Spampatti; Christine Spitzweg; Christoph J Auernhammer
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

Review 5.  The Evolution of Neuroendocrine Tumor Treatment Reflected by ENETS Guidelines.

Authors:  Wouter T Zandee; Wouter W de Herder
Journal:  Neuroendocrinology       Date:  2018-01-10       Impact factor: 4.914

6.  Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.

Authors:  David C Metz; Guillaume Cadiot; Pierre Poitras; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Endocr Oncol       Date:  2017-10-11

7.  Assessment of NETest Clinical Utility in a U.S. Registry-Based Study.

Authors:  Eric Liu; Scott Paulson; Anthony Gulati; Jon Freudman; William Grosh; Sheldon Kafer; Prasanna C Wickremesinghe; Ronald R Salem; Lisa Bodei
Journal:  Oncologist       Date:  2018-08-29

Review 8.  Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications.

Authors:  Giuseppe Fanciulli; Rosaria M Ruggeri; Erika Grossrubatscher; Fabio Lo Calzo; Troy D Wood; Antongiulio Faggiano; Andrea Isidori; Annamaria Colao
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

Review 9.  Workup of Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Joseph S Dillon
Journal:  Surg Oncol Clin N Am       Date:  2020-04       Impact factor: 3.495

10.  Prognostic Utility of 24-Hour Urinary 5-HIAA Doubling Time in Patients With Neuroendocrine Tumors.

Authors:  Amit Tirosh; Naris Nilubol; Dhaval Patel; Electron Kebebew
Journal:  Endocr Pract       Date:  2018-08-07       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.